HIIE and Abdominal Fat Mass in DT2 Postmenopausal Women

Sponsor
University Hospital, Clermont-Ferrand (Other)
Overall Status
Unknown status
CT.gov ID
NCT02352246
Collaborator
Laboratory of metabolic adaptation to exercise under Physiological and Physiopathological conditions (AME2) (Other)
30
1
2
34
0.9

Study Details

Study Description

Brief Summary

Postmenopausal women, as men, are more prone to central or android obesity. Abdominal fat mass is associated with an increase of cardiovascular diseases (CVD). In type 2 diabetic (T2D) patients, the risk of CVD mortality is more than double compared with that in age-matched subjects.

Most exercise programs designed for weight loss have focused on steady-state exercise (SEE) of around 30 min at a moderate intensity several times a week. Disappointingly, these kinds of exercise programs have led to little or no fat loss (Shaw et al. 2006). Accumulating evidence suggests that high intensity intermittent exercise (HIIE) has the potential to be an effective exercise protocol for reducing fat of overweight individuals, especially at the abdominal level (Boutcher 2011, Kessler 2012). Despite these results, HIIE program has never been used in TD2 postmenopausal women to favor a specific decrease of abdominal fat mass.

The aim of our study was to compare the effects of 16-week steady-state exercise (SSE) program with high intensity intermittent exercise (HIIE) program on total abdominal and visceral fat mass in T2D postmenopausal women.

It is hypothesized that HIIE compared to SSE program would result in significantly greater reductions in total abdominal and visceral fat mass.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Physical activity programs steady-state exercise (SSE) program
  • Procedure: Physical activity programs high intensity intermittent exercise (HIIE)
N/A

Detailed Description

Overweight and obesity levels have escalated worldwide, and these trends are occurring in both developed and developing countries. Fat mass and more precisely abdominal fat mass is linked to the development of cardio-vascular diseases (CVD). Postmenopausal women, as men, are more prone to central or android obesity. In type 2 diabetic (T2D) patients, the risk of CVD mortality is more than double compared with that in age-matched subjects.

Most exercise programs designed for weight loss have focused on steady-state exercise (SEE) during at least 30 min, 2 or 3 times a week. Disappointingly, these kinds of exercise programs have led to little or no fat loss (Shaw et al. 2006). Accumulating evidence suggests that high intensity intermittent exercise (HIIE) has the potential to be an effective exercise protocol for reducing fat of overweight individuals, especially at the abdominal level (Boutcher 2011, Kessler 2012). HIIE involves brief high-intensity, anaerobic exercise followed by brief but slightly longer bouts of very low-intensity exercise.

The aim of our study was to compare the effects of 16-week steady-state exercise (SSE) program with high intensity intermittent exercise (HIIE) program on total abdominal and visceral fat mass in T2D postmenopausal women.

30 T2D postmenopausal women will be randomly assigned to SSE (n= 15) or HIIE (n= 15) group. Subjects performed two sessions by week, on bicycle, during 16 weeks.

SSE: For the SSE protocol, each subject performed 40 min at 50% MAP (maximal aerobic power) HIIE: For the HIIE protocol, each subject performed 8 s of sprinting and 12 s of turning the pedals over slowly (between 20 and 30 r.p.m.) for a maximum of 60 repeats a session.

Total body and regional fat content will be measured using dual-energy x-ray absorptiometry (DXA) before and after the intervention (4 months). The contribution of visceral fat to total abdominal fat will be determined from computed tomography (CT).

The effects of HIIE and SSE program on:
  • Total fat mass (and appendicular fat mass) (DXA)

  • Total fat free mass (and appendicular fat free mass) (DXA)

  • Glycemic profile (plasma HbA1c, plasma glucose)

  • Lipid profile (TG, HDL, LDL, total cholesterol)

  • Food behavior after training (questionnaires)

will also be compared.

Gaussian distribution of the data will be tested by the Kolmogorov-Smirnov test. Data will be presented as mean ± standard deviation (SD). Comparisons between groups will be made with Mann & Whitney U test or ANOVA when appropriate. Relationships between data will be assessed by Pearson correlation. Significance will be accepted at the p<0.05 level. Statistical procedures will be performed using Statistica.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Effect of High-Intensity Intermittent Exercise on Abdominal Fat Mass in Type 2 Diabetes Postmenopausal Women.
Study Start Date :
Feb 1, 2015
Anticipated Primary Completion Date :
Jul 1, 2017
Anticipated Study Completion Date :
Dec 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: steady-state exercise (SSE)

The aim of our study was to compare the effects of 16-week steady-state exercise (SSE) program with high intensity intermittent exercise (HIIE) program on total abdominal and visceral fat mass in T2D postmenopausal women.

Procedure: Physical activity programs steady-state exercise (SSE) program
The aim of our study was to compare the effects of 16-week steady-state exercise (SSE) program with high intensity intermittent exercise (HIIE) program on total abdominal and visceral fat mass in T2D postmenopausal women.

Other: high intensity intermittent exercise (HIIE)

The aim of our study was to compare the effects of 16-week steady-state exercise (SSE) program with high intensity intermittent exercise (HIIE) program on total abdominal and visceral fat mass in T2D postmenopausal women.

Procedure: Physical activity programs high intensity intermittent exercise (HIIE)

Outcome Measures

Primary Outcome Measures

  1. loss of abdominal fat mass (g) [at baseline (T0) and after 4 months of training (T4)]

    Total abdominal fat mass will be measured in all patients from DXA using the methodology of Martin et Jensen (1991; L1-L2 to pubic rami) before (baseline, T0) and after 4 months of training (T4).

Secondary Outcome Measures

  1. Change from baseline in visceral fat mass (g) [at baseline (T0) and after 4 months of training (T4)]

    calculated from computer tomography, Sottier et al. 2013

  2. Change from baseline in total fat mass (g) determined from DXA [at baseline (T0) and after 4 months of training (T4)]

    determined from DXA

  3. Change from baseline in total fat free mass (g) determined from DXA [at baseline (T0) and after 4 months of training (T4)]

    determined from DXA

  4. Change from baseline in glycemic profile (plasma HbA1c and plasma glucose measurements) [at T0 and after 4 months of training (T4)]

    plasma HbA1c and plasma glucose measurements

  5. Change from baseline in lipid profile (plasma TG, HDL, LDL and total cholesterol measurements) [at baseline (T0) and after 4 months of training (T4)]

    plasma TG, HDL, LDL and total cholesterol measurements

  6. Change from baseline in food behavior after training (visual analog scale from Flint et al. 2000) [at baseline (T0) and after 4 months of training (T4)]

    visual analog scale from Flint et al. 2000

Eligibility Criteria

Criteria

Ages Eligible for Study:
55 Years to 82 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • postmenopausal women (55- 82 years)

  • T2D

  • BMI ≥ 25 and < 40

  • able to follow an exercise protocol

  • eating behavior and physical activity stable since at least 3 month

Exclusion Criteria:
    • subject not able to perform exercise after medical examination
  • subject not able to perform bicycle exercise (pains)

  • chronic infection

  • use of β-blocker

  • medical treatment that could interfere with the different outcome measures

  • Hormonal Replacement Therapy (HRT)

  • regular consumption of alcohol

  • refusal to sign the consent form

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chu Clermont Ferrand Clermont-Ferrand France 63003

Sponsors and Collaborators

  • University Hospital, Clermont-Ferrand
  • Laboratory of metabolic adaptation to exercise under Physiological and Physiopathological conditions (AME2)

Investigators

  • Principal Investigator: Martine DUCLOS, CHU de Clermont-Ferrand

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Clermont-Ferrand
ClinicalTrials.gov Identifier:
NCT02352246
Other Study ID Numbers:
  • CHU-0220
First Posted:
Feb 2, 2015
Last Update Posted:
Feb 2, 2015
Last Verified:
Jan 1, 2015
Keywords provided by University Hospital, Clermont-Ferrand
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 2, 2015